Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Medtronic
Moodys
Argus Health
Chinese Patent Office
QuintilesIMS
Mallinckrodt
Daiichi Sankyo
AstraZeneca

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020941

« Back to Dashboard

NDA 020941 describes ABREVA, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. Additional details are available on the ABREVA profile page.

The generic ingredient in ABREVA is docosanol. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the docosanol profile page.
Summary for 020941
Tradename:ABREVA
Applicant:Glaxosmithkline
Ingredient:docosanol
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020941
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ABREVA docosanol CREAM;TOPICAL 020941 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0200 0135-0200-01 2 g in 1 TUBE (0135-0200-01)
ABREVA docosanol CREAM;TOPICAL 020941 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0200 0135-0200-03 2 g in 1 BOTTLE, PUMP (0135-0200-03)

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;TOPICALStrength10%
Approval Date:Jul 25, 2000TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Mallinckrodt
Novartis
Johnson and Johnson
Argus Health
Boehringer Ingelheim
Merck
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot